Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study

被引：0
|
作者：
Makoto Sakai
Makoto Sohda
Hideyuki Saito
Kengo Kuriyama
Tomonori Yoshida
Yuji Kumakura
Keigo Hara
Takehiko Yokobori
Tatsuya Miyazaki
Kazutoshi Murata
Shin-ei Noda
Takashi Nakano
Hiroyuki Kuwano
Ken Shirabe
机构：
[1] Gunma University,Department of General Surgical Science, Graduate School of Medicine
[2] Gunma University Graduate School of Medicine,Department of Innovative Cancer Immunotherapy
[3] Gunma University Graduate School of Medicine,Department of Radiation Oncology
[4] International Medical Center,Department of Radiation Oncology
[5] Saitama Medical University,undefined
[6] Fukuoka City Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Cervical esophageal cancer; Chemoradiotherapy; DCF; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1121 / 1126
页数：5
相关论文
共 50 条
  • [21] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Nasopharyngeal Carcinoma
    Komatsu, Masanori
    Arai, Yasuhiro
    Yabuki, Kenichiro
    Sano, Daisuke
    Shiono, Osamu
    Sakuma, Yasunori
    Nishimura, Goushi
    Takahashi, Masahiro
    Taguchi, Takahide
    Oridate, Nobuhiko
    ANTICANCER RESEARCH, 2015, 35 (12) : 6861 - 6867
  • [22] Oncological outcomes of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced squamous cell carcinoma of the external auditory canal: A single-center study
    Yamada, Akihiro
    Shinomiya, Hirotaka
    Uehara, Natsumi
    Iritani, Keisuke
    Tatehara, Shun
    Furukawa, Tatsuya
    Teshima, Masanori
    Miyawaki, Daisuke
    Fujita, Takeshi
    Kakigi, Akinobu
    Kiyota, Naomi
    Sasaki, Ryohei
    Nibu, Ken-ichi
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2023, 45 (10): : 2498 - 2504
  • [23] Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal Cancer
    Shiraishi, Osamu
    Yamasaki, Makoto
    Makino, Tomoki
    Motoori, Masaaki
    Miyata, Hiroshi
    Shinkai, Masayuki
    Kimura, Yutaka
    Hirao, Motohiro
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kobayashi, Kenji
    Yano, Masahiko
    Doki, Yuichiro
    Yasuda, Takushi
    ONCOLOGY, 2017, 92 (02) : 101 - 108
  • [24] Risks of severe adverse events of docetaxel, cisplatin, and 5-fluorouracil (DCF) combination chemotherapy of esophageal cancer
    Yuda, Sayako
    Kato, Ken
    Sasaki, Yusuke
    Takahashi, Naoki
    Shoji, Hirokazu
    Takashima, Atsuo
    Okita, Natsuko T.
    Honma, Yoshitaka
    Iwasa, Satoru
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Nagashina, Kengo
    Boku, Narikazu
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [25] Concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil (5 FU) and cisplatin for locally advanced resectable esophageal cancer: A retrospective study
    Almhanna, Khaldoun
    Hoffe, Sarah
    Shridhar, Ravi
    Strosberg, Jonathan R.
    Dinwoodie, William R.
    Meredith, Kenneth
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [26] The combination of docetaxel, cisplatin, and 5-fluorouracil in advanced gastric cancer: a single-institution experience
    Ben Aharon, Irit
    Purim, Ofer
    Kundel, Yulia
    Brenner, Ronen
    Gordon, Noa
    Sulkes, Aaron
    Brenner, Baruch
    ANTI-CANCER DRUGS, 2012, 23 (03) : 313 - 320
  • [27] Weekly Docetaxel, Cisplatin, and 5-Fluorouracil as Initial Therapy for Patients With Advanced Gastric and Esophageal Cancer
    Overman, Michael J.
    Kazmi, Syed M.
    Jhamb, Jagriti
    Lin, E.
    Yao, James C.
    Abbruzzese, James L.
    Ho, Linus
    Ajani, Jaffer
    Phan, Alexandria
    CANCER, 2010, 116 (06) : 1446 - 1453
  • [28] Induction Chemotherapy with Docetaxel/Cisplatin/5-Fluorouracil for Patients with Node-Positive Esophageal Cancer
    Watanabe, Masayuki
    Nagai, Yohei
    Kinoshita, Kuichi
    Saito, Seiya
    Kurashige, Junji
    Karashima, Ryuichi
    Hirashima, Kotaro
    Sato, Nobutaka
    Imamura, Yu
    Hiyoshi, Yukiharu
    Baba, Yoshifumi
    Iwagami, Shiro
    Miyamoto, Yuji
    Iwatsuki, Masaaki
    Hayashi, Naoko
    Baba, Hideo
    DIGESTION, 2011, 83 (03) : 146 - 152
  • [29] Recurrence Pattern Comparing Preoperative Chemoradiotherapy and Preoperative Chemotherapy with Docetaxel plus 5-Fluorouracil and Cisplatin for Advanced Esophageal Cancer
    Sugase, Takahito
    Sugimura, Keijiro
    Kanemura, Takashi
    Takeoka, Tomohira
    Yamamoto, Masaaki
    Shinno, Naoki
    Hara, Hisashi
    Omori, Takeshi
    Fujii, Yoshiaki
    Mukai, Yosuke
    Mikamori, Manabu
    Hasegawa, Shinichiro
    Haraguchi, Naotsugu
    Akita, Hirofumi
    Nishimura, Junichi
    Wada, Hiroshi
    Matsuda, Chu
    Yasui, Masayoshi
    Miyata, Hiroshi
    ONCOLOGY, 2022, : 655 - 665
  • [30] Efficacy and safety of docetaxel/cisplatin/5-fluorouracil preoperative combination chemotherapy in esophageal cancer patients with extended lymph node metastases
    Tanaka, Tsuyoshi
    Kinoshita, Yoshihiro
    Udagawa, Harushi
    Ueno, Masaki
    Ehara, Kazuhisa
    Haruta, Shusuke
    Kaida, Sachiko
    Nakagawa, Masatoshi
    ESOPHAGUS, 2012, 9 (02) : 99 - 104
12345